Literature DB >> 28585061

Quality of life correlates with muscle strength in patients with dermato- or polymyositis.

Karina B Poulsen1, Helene Alexanderson2,3, Christine Dalgård4, Søren Jacobsen5, Louise Weile6, Louise P Diederichsen7.   

Abstract

The aim of this study was to compare health-related quality of life (HQoL) in adults with dermatomyositis (DM) or polymyositis (PM) with a healthy control group and to assess whether muscle strength was associated with HQoL in patients with DM or PM. A cross-sectional study was performed and included 75 patients with DM or PM and 48 healthy controls. HQoL was assessed by the Short Form 36 questionnaire (SF-36). Muscle strength of the patients was assessed using the Manual Muscle Test-8 (MMT8). Covariables and possible confounding factors were collected by validated tools. Associations were determined in multiple linear regression models. The patients had significantly lower HQoL than the control group in both the physical component summary score (PCS) and the mental component summary score (MCS). Thus, the PCS-difference between groups was 32% (p < 0.001), whereas the MCS-difference was 14% (p < 0.001). Muscle strength was associated with one domain in the patients; Physical Function (β = 1.2; 95% confidence interval 0.37 to 2.1). No statistically significant associations were found between muscle strength and HQoL in the remaining domains. Patients with DM or PM have reduced HQoL compared to healthy controls. Notably, muscle strength was associated with scores of the domain reflecting perceived physical function in patients. These findings corroborate the validity of including selected patient reported outcomes in the evaluation and monitoring of patients with DM or PM.

Entities:  

Keywords:  Dermatomyositis; Muscle strength; Physical functioning; Polymyositis; Quality of life; Short Form 36 (SF-36)

Mesh:

Year:  2017        PMID: 28585061     DOI: 10.1007/s10067-017-3706-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Long-term follow-up of 62 patients with myositis.

Authors:  Janneke van de Vlekkert; Jessica E Hoogendijk; Marianne de Visser
Journal:  J Neurol       Date:  2014-05       Impact factor: 4.849

3.  A comparative study of outcome in myositis and other musculoskeletal disorders assessed using the Nottingham health profile.

Authors:  Y L Chung; H L Mitchell; D A Houssien; H Al-Mahrouki; A J Carr; D L Scott
Journal:  Clin Exp Rheumatol       Date:  2001 Jul-Aug       Impact factor: 4.473

Review 4.  Morbidity and mortality in adult polymyositis and dermatomyositis.

Authors:  Isabelle Marie
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

5.  Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life.

Authors:  Jennifer L Hundley; Christie L Carroll; Wei Lang; Beverly Snively; Gil Yosipovitch; Steven R Feldman; Joseph L Jorizzo
Journal:  J Am Acad Dermatol       Date:  2005-12-02       Impact factor: 11.527

6.  Predictors of Reduced Health-Related Quality of Life in Adult Patients With Idiopathic Inflammatory Myopathies.

Authors:  Michal Feldon; Payam Noroozi Farhadi; Hermine I Brunner; Lukasz Itert; Bob Goldberg; Abdullah Faiq; Jesse Wilkerson; Kathryn M Rose; Lisa G Rider; Frederick W Miller; Edward H Giannini
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-09-21       Impact factor: 4.794

Review 7.  Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies.

Authors:  F W Miller; L G Rider; Y L Chung; R Cooper; K Danko; V Farewell; I Lundberg; C Morrison; L Oakley; I Oakley; C Pilkington; J Vencovsky; K Vincent; D L Scott; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2001-11       Impact factor: 7.580

8.  Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis.

Authors:  A Ponyi; G Borgulya; T Constantin; A Váncsa; L Gergely; K Dankó
Journal:  Rheumatology (Oxford)       Date:  2004-09-20       Impact factor: 7.580

Review 9.  Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).

Authors:  Lisa G Rider; Victoria P Werth; Adam M Huber; Helene Alexanderson; Anand Prahalad Rao; Nicolino Ruperto; Laura Herbelin; Richard Barohn; David Isenberg; Frederick W Miller
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

10.  Cardiac abnormalities assessed by non-invasive techniques in patients with newly diagnosed idiopathic inflammatory myopathies.

Authors:  Louise Pyndt Diederichsen; Jane Angel Simonsen; Axel Cosmus Pyndt Diederichsen; Won Yong Kim; Svend Hvidsten; Mikkel Hougaard; Peter Junker; Ingrid E Lundberg; Henrik Petersen; Esben Søvsø Szocska Hansen; Karl Sannes Eskerud; Susan Due Kay; Søren Jacobsen
Journal:  Clin Exp Rheumatol       Date:  2015-09-07       Impact factor: 4.473

View more
  5 in total

Review 1.  Update on outcome assessment in myositis.

Authors:  Lisa G Rider; Rohit Aggarwal; Pedro M Machado; Jean-Yves Hogrel; Ann M Reed; Lisa Christopher-Stine; Nicolino Ruperto
Journal:  Nat Rev Rheumatol       Date:  2018-04-12       Impact factor: 20.543

Review 2.  Assessment of Physical Activity and Muscle Function in Adult Inflammatory Myopathies.

Authors:  William J Gregory; Didem Saygin
Journal:  Curr Rheumatol Rep       Date:  2022-03-04       Impact factor: 4.592

3.  MRI assessment of the thigh musculature in dermatomyositis and healthy subjects using diffusion tensor imaging, intravoxel incoherent motion and dynamic DTI.

Authors:  E E Sigmund; S H Baete; T Luo; K Patel; D Wang; I Rossi; A Duarte; M Bruno; D Mossa; A Femia; S Ramachandran; D Stoffel; J S Babb; A G Franks; J Bencardino
Journal:  Eur Radiol       Date:  2018-06-04       Impact factor: 5.315

Review 4.  Exercise in Myositis.

Authors:  Helene Alexanderson
Journal:  Curr Treatm Opt Rheumatol       Date:  2018-11-23

5.  Patient and physician discordance of global disease assessment in juvenile dermatomyositis: findings from the Childhood Arthritis & Rheumatology Research Alliance Legacy Registry.

Authors:  Heather Tory; David Zurakowski; Susan Kim
Journal:  Pediatr Rheumatol Online J       Date:  2020-01-15       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.